Unichem Labs jumps on report of sale plans

| Updated on: Oct 12, 2015

Shares of Unichem Laboratories Ltd, a mid-sized Indian drugmaker, today jumped as much as 3 per cent to Rs 315.75.

The drugmaker is exploring the sale of its domestic formulations business, and its proposal “is being studied’’ by private equity firms and strategic investors, a media report said, citing unnamed sources.

Potential suitors could include Teva Pharmaceuticals Ltd , Mylan Inc, Abbott Laboratories Ltd, Sanofi PA, and Pfizer Inc, the report said, citing sources.

Unichem’s Managing Director Prakash Mody denied the report on local television channel CNBC-TV18 on Monday, and said the company had no plans to sell a stake.

The company did not immediately respond to a request for comment by Reuters.

Published on January 22, 2018

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you